Differences in serum concentration with valproate oral solution versus delayed-release divalproex in an adherent patient
Background Several different formulations of valproic acid derivatives are available in the United States. Although these formulations have different absorption characteristics, they are believed to be interchangeable, with the exception of the extended-release product. Case Report A 31-year-old Afr...
Main Author: | Davis Erica A. K. PharmD, BCPS, BCPP |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association of Psychiatric Pharmacists
2023-06-01
|
Series: | Mental Health Clinician |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2023.06.152 |
Similar Items
-
Valproate, divalproex, valpromide: Are the differences in indications justified?
by: Clément Delage, et al.
Published: (2023-02-01) -
Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid
by: Ranel Troy Santos, PharmD, BCPP, et al.
Published: (2023-01-01) -
Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials
by: Chen Qi Zhang, et al.
Published: (2022-04-01) -
An assessment of the clinical equivalence of valproate chrono and extended release divalproex formulations
by: Rajesh B, et al.
Published: (2007-01-01) -
A pilot trial of quetiapine, lithium, or placebo added to divalproex sodium for hypomanic or manic episodes in ambulatory adults with bipolar I disorder
by: Victoria E. Cosgrove, et al.
Published: (2022-03-01)